Načítá se...

Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls – first steps in development of a biomarker

BACKGROUND: Schizophrenia is a severe, disabling and prevalent mental disorder without cure and with a variable, incomplete pharmacotherapeutic response. Prior to onset in adolescence or young adulthood a prodromal period of abnormal symptoms lasting weeks to years has been identified and operationa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Med
Hlavní autoři: Duffy, Frank H., D’Angelo, Eugene, Rotenberg, Alexander, Gonzalez-Heydrich, Joseph
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4630963/
https://ncbi.nlm.nih.gov/pubmed/26525736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0516-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!